Competing risks of mortality in prostate cancer

Arnon Krongrad, Hong Chen Lai, Shenghan Lai

Research output: Contribution to journalArticle

Abstract

Purpose: We have observed that in prostate cancer older age, black race, high stage and no treatment are independently associated with higher disease specific and overall mortality. Because disease nonspecific mortality was not examined one cannot reasonably infer that higher overall mortality is largely due to higher disease specific mortality. To understand better the interactions of independent prognostic variables with overall mortality we jointly evaluated their effects on type of death and time to death. Materials and Methods: Using the prostate cancer patients of the 1973 to 1990 public use tape of the Surveillance, Epidemiology and End Results program, we performed competing risks analysis with multivariate accelerated failure time model to examine if the prognostic factors were associated with type of death and time to death. Results: Older age, black race and no treatment were independently associated with higher relative risk of disease specific and nonspecific mortality. Localized stage was associated with lower and higher disease specific and nonspecific mortality than regional stage, respectively. The relative risks of disease specific and nonspecific mortality were significantly different from each other for all prognostic factors. Conclusions: To our knowledge, a competing risks analysis in prostate cancer has not been done previously. While all prognostic factors were associated with disease specific and nonspecific mortality, the relative contributions of disease specific and nonspecific mortality to overall mortality varied by prognostic factor, with some prognostic factors associated with relatively high disease specific mortality while others were associated with relatively high disease nonspecific mortality. The similarity of the associations of age, race and treatment with disease specific and nonspecific mortality suggests that they mark an unidentified factor(s) that affects patient health nonspecifically. Such a factor(s) may partly or completely explain the association of treatment with lower disease specific mortality.

Original languageEnglish (US)
Pages (from-to)865-868
Number of pages4
JournalJournal of Urology
Volume158
Issue number3
DOIs
StatePublished - Sep 1997
Externally publishedYes

Fingerprint

Prostatic Neoplasms
Mortality
SEER Program
Therapeutics
Multivariate Analysis

Keywords

  • Mortality
  • Prostatic neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Competing risks of mortality in prostate cancer. / Krongrad, Arnon; Lai, Hong Chen; Lai, Shenghan.

In: Journal of Urology, Vol. 158, No. 3, 09.1997, p. 865-868.

Research output: Contribution to journalArticle

@article{1481e4e20a5a4a8b962dbce56f0da57f,
title = "Competing risks of mortality in prostate cancer",
abstract = "Purpose: We have observed that in prostate cancer older age, black race, high stage and no treatment are independently associated with higher disease specific and overall mortality. Because disease nonspecific mortality was not examined one cannot reasonably infer that higher overall mortality is largely due to higher disease specific mortality. To understand better the interactions of independent prognostic variables with overall mortality we jointly evaluated their effects on type of death and time to death. Materials and Methods: Using the prostate cancer patients of the 1973 to 1990 public use tape of the Surveillance, Epidemiology and End Results program, we performed competing risks analysis with multivariate accelerated failure time model to examine if the prognostic factors were associated with type of death and time to death. Results: Older age, black race and no treatment were independently associated with higher relative risk of disease specific and nonspecific mortality. Localized stage was associated with lower and higher disease specific and nonspecific mortality than regional stage, respectively. The relative risks of disease specific and nonspecific mortality were significantly different from each other for all prognostic factors. Conclusions: To our knowledge, a competing risks analysis in prostate cancer has not been done previously. While all prognostic factors were associated with disease specific and nonspecific mortality, the relative contributions of disease specific and nonspecific mortality to overall mortality varied by prognostic factor, with some prognostic factors associated with relatively high disease specific mortality while others were associated with relatively high disease nonspecific mortality. The similarity of the associations of age, race and treatment with disease specific and nonspecific mortality suggests that they mark an unidentified factor(s) that affects patient health nonspecifically. Such a factor(s) may partly or completely explain the association of treatment with lower disease specific mortality.",
keywords = "Mortality, Prostatic neoplasms",
author = "Arnon Krongrad and Lai, {Hong Chen} and Shenghan Lai",
year = "1997",
month = "9",
doi = "10.1016/S0022-5347(01)64341-6",
language = "English (US)",
volume = "158",
pages = "865--868",
journal = "Journal of Urology",
issn = "0022-5347",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - Competing risks of mortality in prostate cancer

AU - Krongrad, Arnon

AU - Lai, Hong Chen

AU - Lai, Shenghan

PY - 1997/9

Y1 - 1997/9

N2 - Purpose: We have observed that in prostate cancer older age, black race, high stage and no treatment are independently associated with higher disease specific and overall mortality. Because disease nonspecific mortality was not examined one cannot reasonably infer that higher overall mortality is largely due to higher disease specific mortality. To understand better the interactions of independent prognostic variables with overall mortality we jointly evaluated their effects on type of death and time to death. Materials and Methods: Using the prostate cancer patients of the 1973 to 1990 public use tape of the Surveillance, Epidemiology and End Results program, we performed competing risks analysis with multivariate accelerated failure time model to examine if the prognostic factors were associated with type of death and time to death. Results: Older age, black race and no treatment were independently associated with higher relative risk of disease specific and nonspecific mortality. Localized stage was associated with lower and higher disease specific and nonspecific mortality than regional stage, respectively. The relative risks of disease specific and nonspecific mortality were significantly different from each other for all prognostic factors. Conclusions: To our knowledge, a competing risks analysis in prostate cancer has not been done previously. While all prognostic factors were associated with disease specific and nonspecific mortality, the relative contributions of disease specific and nonspecific mortality to overall mortality varied by prognostic factor, with some prognostic factors associated with relatively high disease specific mortality while others were associated with relatively high disease nonspecific mortality. The similarity of the associations of age, race and treatment with disease specific and nonspecific mortality suggests that they mark an unidentified factor(s) that affects patient health nonspecifically. Such a factor(s) may partly or completely explain the association of treatment with lower disease specific mortality.

AB - Purpose: We have observed that in prostate cancer older age, black race, high stage and no treatment are independently associated with higher disease specific and overall mortality. Because disease nonspecific mortality was not examined one cannot reasonably infer that higher overall mortality is largely due to higher disease specific mortality. To understand better the interactions of independent prognostic variables with overall mortality we jointly evaluated their effects on type of death and time to death. Materials and Methods: Using the prostate cancer patients of the 1973 to 1990 public use tape of the Surveillance, Epidemiology and End Results program, we performed competing risks analysis with multivariate accelerated failure time model to examine if the prognostic factors were associated with type of death and time to death. Results: Older age, black race and no treatment were independently associated with higher relative risk of disease specific and nonspecific mortality. Localized stage was associated with lower and higher disease specific and nonspecific mortality than regional stage, respectively. The relative risks of disease specific and nonspecific mortality were significantly different from each other for all prognostic factors. Conclusions: To our knowledge, a competing risks analysis in prostate cancer has not been done previously. While all prognostic factors were associated with disease specific and nonspecific mortality, the relative contributions of disease specific and nonspecific mortality to overall mortality varied by prognostic factor, with some prognostic factors associated with relatively high disease specific mortality while others were associated with relatively high disease nonspecific mortality. The similarity of the associations of age, race and treatment with disease specific and nonspecific mortality suggests that they mark an unidentified factor(s) that affects patient health nonspecifically. Such a factor(s) may partly or completely explain the association of treatment with lower disease specific mortality.

KW - Mortality

KW - Prostatic neoplasms

UR - http://www.scopus.com/inward/record.url?scp=0030811089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030811089&partnerID=8YFLogxK

U2 - 10.1016/S0022-5347(01)64341-6

DO - 10.1016/S0022-5347(01)64341-6

M3 - Article

VL - 158

SP - 865

EP - 868

JO - Journal of Urology

JF - Journal of Urology

SN - 0022-5347

IS - 3

ER -